These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 25996983)
1. The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors. Gatta V; Petrovic B; Campadelli-Fiume G PLoS Pathog; 2015 May; 11(5):e1004907. PubMed ID: 25996983 [TBL] [Abstract][Full Text] [Related]
2. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins. Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G PLoS Pathog; 2017 Apr; 13(4):e1006352. PubMed ID: 28423057 [TBL] [Abstract][Full Text] [Related]
3. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells. Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G J Virol; 2017 May; 91(10):. PubMed ID: 28250120 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors. Leoni V; Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G J Virol; 2018 Mar; 92(6):. PubMed ID: 29263255 [TBL] [Abstract][Full Text] [Related]
6. Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells. Petrovic B; Leoni V; Gatta V; Zaghini A; Vannini A; Campadelli-Fiume G J Virol; 2018 Mar; 92(6):. PubMed ID: 29263257 [TBL] [Abstract][Full Text] [Related]
7. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs. Ikeda H; Uchida H; Okubo Y; Shibata T; Sasaki Y; Suzuki T; Hamada-Uematsu M; Hamasaki R; Okuda K; Yamaguchi M; Kojima M; Tanaka M; Hamada H; Tahara H J Virol; 2021 Apr; 95(9):. PubMed ID: 33627393 [TBL] [Abstract][Full Text] [Related]
8. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors. Atanasiu D; Cairns TM; Whitbeck JC; Saw WT; Rao S; Eisenberg RJ; Cohen GH mBio; 2013 Feb; 4(2):. PubMed ID: 23443004 [TBL] [Abstract][Full Text] [Related]
9. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus. Okubo Y; Uchida H; Wakata A; Suzuki T; Shibata T; Ikeda H; Yamaguchi M; Cohen JB; Glorioso JC; Tagaya M; Hamada H; Tahara H J Virol; 2016 Dec; 90(24):11096-11105. PubMed ID: 27707922 [TBL] [Abstract][Full Text] [Related]
10. Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2. Menotti L; Cerretani A; Hengel H; Campadelli-Fiume G J Virol; 2008 Oct; 82(20):10153-61. PubMed ID: 18684832 [TBL] [Abstract][Full Text] [Related]
11. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD. Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715 [TBL] [Abstract][Full Text] [Related]
12. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses. Menotti L; Avitabile E; Gatta V; Malatesta P; Petrovic B; Campadelli-Fiume G Viruses; 2018 Jun; 10(7):. PubMed ID: 29966356 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1. Rogalin HB; Heldwein EE J Virol; 2016 Nov; 90(22):10321-10328. PubMed ID: 27605677 [TBL] [Abstract][Full Text] [Related]
14. A Functional Interaction between Herpes Simplex Virus 1 Glycoprotein gH/gL Domains I and II and gD Is Defined by Using Alphaherpesvirus gH and gL Chimeras. Fan Q; Longnecker R; Connolly SA J Virol; 2015 Jul; 89(14):7159-69. PubMed ID: 25926636 [TBL] [Abstract][Full Text] [Related]
15. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage. Fan Q; Kopp S; Connolly SA; Muller WJ; Longnecker R Sci Rep; 2017 Mar; 7():43712. PubMed ID: 28255168 [TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras. Cairns TM; Milne RS; Ponce-de-Leon M; Tobin DK; Cohen GH; Eisenberg RJ J Virol; 2003 Jun; 77(12):6731-42. PubMed ID: 12767993 [TBL] [Abstract][Full Text] [Related]
17. The multipartite system that mediates entry of herpes simplex virus into the cell. Campadelli-Fiume G; Amasio M; Avitabile E; Cerretani A; Forghieri C; Gianni T; Menotti L Rev Med Virol; 2007; 17(5):313-26. PubMed ID: 17573668 [TBL] [Abstract][Full Text] [Related]
18. Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes. Hilterbrand AT; Daly RE; Heldwein EE mBio; 2021 Mar; 12(2):. PubMed ID: 33653890 [TBL] [Abstract][Full Text] [Related]
19. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread. Shibata T; Uchida H; Shiroyama T; Okubo Y; Suzuki T; Ikeda H; Yamaguchi M; Miyagawa Y; Fukuhara T; Cohen JB; Glorioso JC; Watabe T; Hamada H; Tahara H Gene Ther; 2016 Jun; 23(6):479-88. PubMed ID: 26905369 [TBL] [Abstract][Full Text] [Related]
20. The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1. Zhou G; Avitabile E; Campadelli-Fiume G; Roizman B J Virol; 2003 Mar; 77(6):3759-67. PubMed ID: 12610150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]